In May, the FDA approved GSK’s GSK RSV vaccine, Arexvy, forthe prevention of LRTD caused by RSV in older adults aged 60+ years. This was the first RSV vaccine for older adults to be approved ...

The EU on Friday authorised the sale of a vaccine to protect infants from respiratory syncytial virus (RSV), a disease that in worst cases can lead to pneumonia and bronchiolitis. The bloc-wide ...

The Food and Drug Administration approved an RSV vaccine for adults in May, the first vaccine of its kind. The shot, known by its brand name Arexvy, was nearly 83% effective in preventing an RSV ...

NORTH TEXAS (CBSNewsTexas.com) – For the first time ever, an RSV vaccine has become available to those at high-risk. This comes as cases of the respiratory illness are rising in Texas and across ...

New tests of a recently approved vaccine for respiratory syncytial virus—RSV—show the shot remains effective against a range ...

The FDA has approved the first long acting drug to protect infants and toddlers from the respiratory virus known as RSV. The antibody preventive therapy called, was approved Monday for injection ...

GSK plc has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its Arexvy (respiratory ...

GSK has received approval from Japan’s MHLW for RSV vaccine Arexvy to prevent RSV disease in adults aged over 60 years ...

WASHINGTON (AP) — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection. RSV is ...

GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare ...